Sven De Backer

Algemeen directeur at IGS Westlede
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Ghent Metropolitan Area, BE

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Belgium
    • Government Relations Services
    • 1 - 100 Employee
    • Algemeen directeur
      • Aug 2020 - Present

    • Interim Manager
      • Sep 2018 - Aug 2020

    • United States
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
      • Jan 2009 - Aug 2018

      • Jan 2017 - Jul 2018

    • CEO
      • Jun 2010 - Dec 2016

      RHEI Pharmaceuticals HK Ltd (RHEI) is a global pharmaceuticals business development company, with a special focus on bringing core medicines from the U.S., Europe and Japan, into the fast-growing Chinese marketplace. RHEI in-licenses approved and late stage pharmaceutical products from these reference countries, and applies its development and regulatory expertise to bring these important therapies to China. RHEI’s internal capabilities encompass business development, regulatory approval and clinical development– combining a western approach to pharmaceuticals with Chinese professionals that are highly experienced in the region. They use their development capabilities and network of preferred commercial partners to help other pharmaceutical companies introduce their products into specific niche markets, such as the European institutional healthcare market and the Chinese hospital market. Currently, RHEI is in the process of bringing several products in its pipeline through the clinical development and regulatory steps essential to entering these products in the Chinese market. As from 2010 on, during a 2nd phase of expansion, RHEI started accelerating its commercial activities, in part through preferred distribution partnerships. Later on, in a 3rd phase, the company will focus on directly controlling the manufacturing aspects of its product portfolio. RHEI has particular expertise in the areas of oncology, women’s health, infectious diseases and dermatology. RHEI applies its unique offering to branded pharmaceuticals through its close relationship with selected preferred commercial partners. RHEI is headquartered in Hong Kong and has operations in the US and China. Show less

    • Non Executive Director
      • Jun 2008 - Dec 2015

    • Interim Manager
      • Jul 2005 - Oct 2007

    • Netherlands
    • Photography
    • 1 - 100 Employee
    • Business Unit Manager
      • Jun 1997 - May 2005

    • Investment Officer
      • 1995 - 1997

    • Financial Analyst
      • 1993 - 1995

Education

  • Vlerick Leuven-Gent Management School
    Master, Financial Management
    1993 - 1993
  • University of Ghent
    Master in Applied Economics, Economics
    1988 - 1992
  • Atheneum Gent Voskenslaan
    1982 - 1988

Community

You need to have a working account to view this content. Click here to join now